CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 322276-322620 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2470","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"TextSentencer_T2471","span":{"begin":12,"end":138},"obj":"Sentence"},{"id":"TextSentencer_T2472","span":{"begin":139,"end":344},"obj":"Sentence"},{"id":"T98925","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T9850","span":{"begin":12,"end":138},"obj":"Sentence"},{"id":"T15290","span":{"begin":139,"end":344},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conclusion: Groups of both vaccine and non-vaccine serotypes can be categorised according to their propensity to expand and to acquire MR. Serotype 19F slightly decreases in prevalence but increases in MR rate, while serotype 19 not F both increases in prevalence and acquires resistance at a rate that is proportional to the expansion process."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T206","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T207","span":{"begin":12,"end":138},"obj":"Sentence"},{"id":"T208","span":{"begin":139,"end":344},"obj":"Sentence"}],"text":"Conclusion: Groups of both vaccine and non-vaccine serotypes can be categorised according to their propensity to expand and to acquire MR. Serotype 19F slightly decreases in prevalence but increases in MR rate, while serotype 19 not F both increases in prevalence and acquires resistance at a rate that is proportional to the expansion process."}

{"project":"Epistemic_Statements","denotations":[{"id":"T690","span":{"begin":0,"end":344},"obj":"Epistemic_statement"}],"text":"Conclusion: Groups of both vaccine and non-vaccine serotypes can be categorised according to their propensity to expand and to acquire MR. Serotype 19F slightly decreases in prevalence but increases in MR rate, while serotype 19 not F both increases in prevalence and acquires resistance at a rate that is proportional to the expansion process."}